Contributions of the Japanese Gynecologic Oncology Group (JGOG) in Improving the Quality of Life in Women With Gynecological Malignancies

Affiliations

¹ Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, 5-Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan. futagami@hirosaki-u.ac.jp.
² Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, 5-Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan.
³ Department of Obstetrics and Gynecology, Graduate School of Medicine, Tohoku University, Sendai, 980-8574, Japan.
⁴ Department of Obstetrics and Gynecology, Tottori University School of Medicine, 36-1 Nishimachi, Yonago, 683-8504, Japan.
⁵ Department of Obstetrics and Gynecology, Yokohama City University Hospital, Fukuura 3-9, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
⁶ Department of Obstetrics and Gynecology, St. Marianna University School of Medicine, 2-16-1 Sugo, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan.
⁷ Department of Obstetrics and Gynecology, Tokyo Medical University Ibaraki Medical Center, 3-20-1 Chuo, Ami-cho, Inashiki-gun, Ibaraki, 300-0395, Japan.
⁸ Department of Obstetrics and Gynecology, Graduate School of Medical Science, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa, 903-0215, Japan.
⁹ Gynecologic Oncology, Sapporo West Kojinkai Clinic, 1-1-1-30 Miyanosawa, Nishi-ku, Sapporo, 063-0051, Japan.
¹⁰ Department of Obstetrics and Gynecology, Iwate Medical University, 19-1, Uchimaru, Morioka, Iwate, 020-8505, Japan.

PMID: 28303492
DOI: 10.1007/s11912-017-0580-y

Review

Contributions of the Japanese Gynecologic Oncology Group (JGOG) in Improving the Quality of Life in Women With Gynecological Malignancies

Masayuki Futagami et al. Curr Oncol Rep. 2017 Apr.

. 2017 Apr;19(4):25.

doi: 10.1007/s11912-017-0580-y.

Authors

Affiliations

¹ Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, 5-Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan. futagami@hirosaki-u.ac.jp.
² Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, 5-Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan.
³ Department of Obstetrics and Gynecology, Graduate School of Medicine, Tohoku University, Sendai, 980-8574, Japan.
⁴ Department of Obstetrics and Gynecology, Tottori University School of Medicine, 36-1 Nishimachi, Yonago, 683-8504, Japan.
⁵ Department of Obstetrics and Gynecology, Yokohama City University Hospital, Fukuura 3-9, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
⁶ Department of Obstetrics and Gynecology, St. Marianna University School of Medicine, 2-16-1 Sugo, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan.
⁷ Department of Obstetrics and Gynecology, Tokyo Medical University Ibaraki Medical Center, 3-20-1 Chuo, Ami-cho, Inashiki-gun, Ibaraki, 300-0395, Japan.
⁸ Department of Obstetrics and Gynecology, Graduate School of Medical Science, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa, 903-0215, Japan.
⁹ Gynecologic Oncology, Sapporo West Kojinkai Clinic, 1-1-1-30 Miyanosawa, Nishi-ku, Sapporo, 063-0051, Japan.
¹⁰ Department of Obstetrics and Gynecology, Iwate Medical University, 19-1, Uchimaru, Morioka, Iwate, 020-8505, Japan.

PMID: 28303492
DOI: 10.1007/s11912-017-0580-y

Abstract

The Japanese Gynecologic Oncology Group (JGOG) is leading Japan in the treatment of gynecological malignancies. The JGOG consists of three treatment committees focusing on uterine cervical cancer, endometrial cancer, and ovarian cancer. Each committee makes efforts to improve treatment and diagnosis. In addition, the Supportive and Palliative Care Committee was established in 2015. Novel studies of supportive care and palliative care have been initiated by this committee. Furthermore, surveys about not only treatment results such as overall survival rates but also quality of life (QOL) and cost-effectiveness assessments are performed by the ovarian cancer committee. Improvements of patients' QOL in the treatment of gynecological malignancies were divided into three concepts as follows: QOL associated with cancer treatment, health care after cancer therapy, and progression of cancer. In this review, we report the contributions and future plans for the improvement of QOL in patients with gynecological malignancies.

Keywords: Gynecological malignancies; JGOG; QOL; Supportive and Palliative Care Committee.

PubMed Disclaimer

Cited by

New small-molecule compound Hu-17 inhibits estrogen biosynthesis by aromatase in human ovarian granulosa cancer cells.
Xi Y, Liu J, Wang H, Li S, Yi Y, Du Y. Xi Y, et al. Cancer Med. 2020 Dec;9(23):9081-9095. doi: 10.1002/cam4.3492. Epub 2020 Oct 1. Cancer Med. 2020. PMID: 33002342 Free PMC article.

References

1. Gynecol Oncol. 2015 Jun;137(3):436-42 - PubMed
1. Int J Clin Oncol. 2015 Apr;20(2):240-8 - PubMed
1. J Gynecol Oncol. 2014 Jul;25(3):198-205 - PubMed
1. JAMA. 1983 Dec 9;250(22):3072-6 - PubMed
1. Jpn J Clin Oncol. 2010 Aug;40(8):739-45 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Contributions of the Japanese Gynecologic Oncology Group (JGOG) in Improving the Quality of Life in Women With Gynecological Malignancies

Affiliations

Contributions of the Japanese Gynecologic Oncology Group (JGOG) in Improving the Quality of Life in Women With Gynecological Malignancies

Authors

Affiliations

Abstract

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources